International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 December 2015

Summary

 

IBT Portfolio NAV (m)

239

Number of Portfolio Companies

92

Quoted Investments

65

Unquoted Investments

27

 

Quoted / Unquoted Split
NAV by Geography

Quoted

92%

United States / Canada

83%

Unquoted

8%

Europe

17%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

87%

Large-Cap (>$10bn)

53%

Medical Devices

2%

Mid-Cap (>$1bn, <$10bn)

26%

Specialty Pharma

10%

Small-Cap (<$1bn)

13%

Life Sciences, Tools

1%

Unquoted

8%

Total100%

Total

100%

 

 

NAV by Portfolio Profitability

 

 

 

Profitable

54%

Turning Profitable 2014

9%

Unprofitable

37%

Total

100%